Natco Pharma to raise Rs.1,279-Cr via rights issue

Publicly listed, Hyderabad-based Natco Pharma is to raise up to INR 1,279.35 crore through a rights issue. The company plans to issue up to 1,70,58,082 equity shares, each with a face value of INR 2, at an issue price of INR 750 per share.The pharmaceutical firm has set an entitlement ratio of 2 rights equity shares for every 21 fully paid-up equity shares held by eligible shareholders. The rights issue is scheduled to open on October 12, 2026, and close on October 22, 2026, with an on-market renunciation period between October 12 and October 16, 2026.Upon full subscription to the rights issue, the company’s total outstanding equity shares will increase from 17,91,09,870 shares to 19,61,67,952 shares.